The Stem Cell Controversy In Intellectual Property In EuropeTuesday, 22 April 2014 at 14:00 Add to Calendar ▼2014-04-22 14:00:002014-04-22 15:00:00Europe/LondonThe Stem Cell Controversy In Intellectual Property In EuropeClinical Translation of Stem Cells 2014 in Palm Springs, California, USAPalm Springs, California, USASELECTBIOenquiries@selectbiosciences.com Stem cell based technology offers unique opportunities for potentially life-changing therapies, but nevertheless remains one of the most controversial and vigorously debated fields of scientific research. Patent rights have been developed to arguably protect and foster such scientific advancement, and, since their inception, have also explicitly rejected the protection of inventions based on unethical research, or research contrary to the ordre public. However, recent decisions by the Technical Boards of Appeal of the European Patent Office seem to indicate that rather than interpreting the implementing provisions narrowly as proscribed, the definition of patentable subject matter is being swayed by the changing popular opinions of various member countries as reflected in their high-court decisions. This presentation seeks to provide an overview of the changing positions taken by national and international bodies with respect to stem cell technology and its impact on the potential for future patent protections. |